Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,882 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis.
Kimura H, Kanahara N, Komatsu N, Ishige M, Muneoka K, Yoshimura M, Yamanaka H, Suzuki T, Komatsu H, Sasaki T, Hashimoto T, Hasegawa T, Shiina A, Ishikawa M, Sekine Y, Shiraishi T, Watanabe H, Shimizu E, Hashimoto K, Iyo M. Kimura H, et al. Among authors: yamanaka h. Schizophr Res. 2014 May;155(1-3):52-8. doi: 10.1016/j.schres.2014.02.022. Epub 2014 Mar 23. Schizophr Res. 2014. PMID: 24667073 Free article.
Does hypofrontality expand to global brain area in progression of schizophrenia?: a cross-sectional study between first-episode and chronic schizophrenia.
Kanahara N, Shimizu E, Sekine Y, Uchida Y, Shibuya T, Yamanaka H, Hashimoto T, Asaka T, Sasaki T, Miyatake R, Ohkami T, Fukami G, Fujisaki M, Watanabe H, Shirayama Y, Hayashi H, Hashimoto K, Asano M, Iyo M. Kanahara N, et al. Among authors: yamanaka h. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):410-5. doi: 10.1016/j.pnpbp.2008.12.017. Epub 2009 Jan 6. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 19166894
Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up.
Kimura H, Kanahara N, Sasaki T, Komatsu N, Ishige M, Muneoka K, Ino H, Yoshimura K, Yamanaka H, Suzuki T, Komatsu H, Watanabe H, Shimizu E, Iyo M. Kimura H, et al. Among authors: yamanaka h. J Psychopharmacol. 2016 Aug;30(8):795-802. doi: 10.1177/0269881116655978. Epub 2016 Jul 1. J Psychopharmacol. 2016. PMID: 27371496
The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study.
Kanahara N, Takase M, Sasaki T, Honma M, Fujita Y, Tadokoro S, Suzuki H, Yamanaka H, Noda S, Yanahashi S, Saiga T, Komatsu N, Simoyama T, Iyo M. Kanahara N, et al. Among authors: yamanaka h. Int Clin Psychopharmacol. 2020 Nov;35(6):338-344. doi: 10.1097/YIC.0000000000000322. Int Clin Psychopharmacol. 2020. PMID: 32868522 Clinical Trial.
1,882 results